Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-07-09 4:14 pm Sale |
2025-06-30 | 13G | Talen Energy Corporation TLN |
Rubric Capital Management LP | 4,505,302 9.900% |
-1,618,198 (-26.43%) |
Filing History |
| 2025-07-09 4:12 pm Sale |
2025-06-30 | 13G | QuidelOrtho Corporation QDEL |
Rubric Capital Management LP | 4,637,738 6.860% |
-912,262 (-16.44%) |
Filing History |
| 2025-07-09 4:10 pm Purchase |
2025-06-30 | 13G | OPKO Health, Inc. OPK |
Rubric Capital Management LP | 47,791,243 6.030% |
47,791,243 (New Position) |
Filing History |
| 2025-07-09 4:09 pm Purchase |
2025-06-30 | 13G | Integra LifeSciences Holdings Corporation IART |
Rubric Capital Management LP | 7,353,934 9.460% |
2,710,262 (+58.36%) |
Filing History |
| 2025-07-09 4:08 pm Sale |
2025-06-30 | 13G | Ovid Therapeutics Inc. OVID |
Rubric Capital Management LP | 478,533 0.670% |
-4,837,436 (-91.00%) |
Filing History |
| 2025-07-09 4:07 pm Sale |
2025-06-30 | 13G | Adaptive Biotechnologies Corporation ADPT |
Rubric Capital Management LP | 6,256,847 4.120% |
-8,143,153 (-56.55%) |
Filing History |
| 2025-07-09 4:06 pm Purchase |
2025-06-30 | 13G | Kiniksa Pharmaceuticals, Ltd. KNSA |
Rubric Capital Management LP | 3,909,806 9.240% |
526,567 (+15.56%) |
Filing History |
| 2025-07-09 4:06 pm Purchase |
2025-06-30 | 13G | Trevi Therapeutics, Inc. TRVI |
Rubric Capital Management LP | 8,531,860 7.120% |
4,326,731 (+102.89%) |
Filing History |
| 2025-07-09 4:04 pm Purchase |
2025-06-30 | 13G | TransAlta Corporation TAC |
Rubric Capital Management LP | 15,948,151 5.380% |
15,948,151 (New Position) |
Filing History |
| 2025-05-14 4:04 pm Purchase |
2025-03-31 | 13G | Integra LifeSciences Holdings Corporation IART |
Rubric Capital Management LP | 4,643,672 6.010% |
4,643,672 (New Position) |
Filing History |
| 2025-05-14 4:04 pm Purchase |
2025-03-31 | 13G | Collegium Pharmaceutical, Inc. COLL |
Rubric Capital Management LP | 3,000,000 9.340% |
650,000 (+27.66%) |
Filing History |
| 2025-05-14 4:04 pm Sale |
2025-03-31 | 13G | Dole plc DOLE |
Rubric Capital Management LP | 4,155,656 4.370% |
-985,732 (-19.17%) |
Filing History |
| 2025-05-14 4:04 pm Sale |
2025-03-31 | 13G | GoodRx Holdings, Inc. GDRX |
Rubric Capital Management LP | 0 0.000% |
-5,804,628 (Position Closed) |
Filing History |
| 2025-05-14 4:04 pm Purchase |
2025-03-31 | 13G | Golar LNG Limited GLNG |
Rubric Capital Management LP | 8,975,149 8.590% |
1,264,938 (+16.41%) |
Filing History |
| 2025-05-14 4:04 pm Purchase |
2025-03-31 | 13G | Kiniksa Pharmaceuticals, Ltd. KNSA |
Rubric Capital Management LP | 3,383,239 8.050% |
964,136 (+39.86%) |
Filing History |
| 2025-05-14 4:04 pm Purchase |
2025-03-31 | 13G | New Fortress Energy Inc. NFE |
Rubric Capital Management LP | 24,338,675 8.890% |
9,338,675 (+62.26%) |
Filing History |
| 2025-02-13 4:01 pm Sale |
2024-12-31 | 13G | Talen Energy Corporation TLN |
Rubric Capital Management LP | 6,123,500 13.320% |
-5,245,114 (-46.14%) |
Filing History |
| 2025-02-13 4:01 pm Purchase |
2024-12-31 | 13G | Collegium Pharmaceutical, Inc. COLL |
Rubric Capital Management LP | 2,350,000 7.290% |
1,100,000 (+88.00%) |
Filing History |
| 2025-02-13 4:01 pm Purchase |
2024-12-31 | 13G | QuidelOrtho Corporation QDEL |
Rubric Capital Management LP | 5,550,000 8.250% |
1,350,000 (+32.14%) |
Filing History |
| 2025-02-13 4:01 pm Purchase |
2024-12-31 | 13G | GoodRx Holdings, Inc. GDRX |
Rubric Capital Management LP | 5,804,628 5.570% |
1,124,600 (+24.03%) |
Filing History |